Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C. Carbon

Showing results (1-10 of 332) with videos related to

Pageof 34
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 7, 2002
How to evaluate the ecologic impact of antibiotics in phase III trialsC Carbon
Medecine Et Maladies Infectieuses|November 1, 2005
C Carbon
Chemotherapy|October 5, 2001
Optimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity)C Carbon
Bulletin De L'Academie Nationale De Medecine|April 1, 1995
[Contribution of the experimental model of bacterial endocarditis]C Carbon
Presse Medicale (Paris, France : 1983)|December 16, 1987
[Indications and limits of cefotaxime monotherapy]C Carbon
Pathologie-Biologie|June 1, 1995
[Azithromycin: from macrolides to azalides]C Carbon
La Nouvelle Presse Medicale|June 15, 1974
[How to choose An antistaphylococcal antibiotic]C Carbon
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1990
Significance of tissue levels for prediction of antibiotic efficacy and determination of dosageC Carbon
Pathologie-Biologie|April 1, 1990
[Antibiotics and anti-inflammatory agents: drug interactions]C Carbon
Revue De L'Infirmiere|April 1, 1982
[Malaria]C Carbon
Pageof 34

Showing results (1-10 of 332) with videos related to

Sort By:
Pageof 34
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 7, 2002
How to evaluate the ecologic impact of antibiotics in phase III trialsC Carbon
Medecine Et Maladies Infectieuses|November 1, 2005
C Carbon
Chemotherapy|October 5, 2001
Optimal treatment strategies for community-acquired pneumonia: high-risk patients (geriatric and with comorbidity)C Carbon
Bulletin De L'Academie Nationale De Medecine|April 1, 1995
[Contribution of the experimental model of bacterial endocarditis]C Carbon
Presse Medicale (Paris, France : 1983)|December 16, 1987
[Indications and limits of cefotaxime monotherapy]C Carbon
Pathologie-Biologie|June 1, 1995
[Azithromycin: from macrolides to azalides]C Carbon
La Nouvelle Presse Medicale|June 15, 1974
[How to choose An antistaphylococcal antibiotic]C Carbon
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 1990
Significance of tissue levels for prediction of antibiotic efficacy and determination of dosageC Carbon
Pathologie-Biologie|April 1, 1990
[Antibiotics and anti-inflammatory agents: drug interactions]C Carbon
Revue De L'Infirmiere|April 1, 1982
[Malaria]C Carbon
Pageof 34